Financial statements Amber Pharm
Cash inflows of AMBER PHARM
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Net cash from operating expenses | 439 509,46 | 312 875,52 | 1 366 101,66 | 225 829,22 |
| Net cash flow from investing activities | -484 486,58 | -86 899,99 | -1 741 402,00 | -37 695,47 |
| Net cash flow from financial activities | -189 065,75 | -110 109,38 | 574 733,85 | -168 746,32 |
| Total net cash flow | -234 042,87 | 115 866,15 | 199 433,51 | 19 387,43 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.